Definition and diagnostic implications of gemistocytic astrocytomas: a pathological perspective.

作者: Tarik Tihan , Poonam Vohra , Mitchel S. Berger , G. Evren Keles

DOI: 10.1007/S11060-005-4897-2

关键词: Who gradePerspective (graphical)Gemistocytic AstrocytomaIntensive care medicineAstrocytomaGemistocytic AstrocytomasPathologyPathologicalClinical significanceDiffuse AstrocytomaMedicine

摘要: Gemistocytic astrocytoma still continues to be enigmatic; both in terms of definition and prognostic implications. The major issue contention has been the clinical relevance this pathological entity. currently accepted gemistocytic requires 20% or more gemistocytes, considers neoplasm as a diffuse astrocytoma, which is WHO grade II tumor. Some suggest that morphology should considered evidence higher astrocytoma. However, there no consensus on percentage gemistocytes associated with worse prognosis than otherwise expected. Given reported cases series, it not clear portends aggressive biology when all else equal. There need for studies sufficient numbers well-matched non-gemistocytic astrocytic neoplasms decide whether upgrading tumor 'significant' number justifiable. This article presents critical review existing brief mention our experience from perspective.

参考文章(41)
Weekes-Seifert S, Kalff R, Gullotta F, Möhrer U, Böker Dk, Mononuclear infiltrates in human intracranial tumors as a prognostic factor. Influence of preoperative steroid treatment. I. Glioblastoma. Clinical Neuropathology. ,vol. 3, pp. 143- ,(1984)
Johan M. Kros, Natanja Waarsenburg, Donal P. Hayes, Wim C.J. Hop, Herman van Dekken, Cytogenetic analysis of gemistocytic cells in gliomas. Journal of Neuropathology and Experimental Neurology. ,vol. 59, pp. 679- 686 ,(2000) , 10.1093/JNEN/59.8.679
P. Kleihues, P. C. Burger, B. W. Scheithauer, Histological Classification of Tumours of the Central Nervous System Springer Berlin Heidelberg. pp. 5- 10 ,(1993) , 10.1007/978-3-642-84988-6_2
J Takeuchi, R O Barnard, Perivascular lymphocytic cuffing in astrocytomas Acta Neuropathologica. ,vol. 35, pp. 265- 271 ,(1976)
H Ohgaki, K Watanabe, Y Yonekawa, O Tachibana, P Kleihues, Role of gemistocytes in astrocytoma progression. Laboratory Investigation. ,vol. 76, pp. 277- 284 ,(1997)
Rui M Reis, Akira Hara, Paul Kleihues, Hiroko Ohgaki, None, Genetic evidence of the neoplastic nature of gemistocytes in astrocytomas. Acta Neuropathologica. ,vol. 102, pp. 422- 425 ,(2001) , 10.1007/S004010100452
Lucien Jules Rubinstein, Dorothy S. Russell, Pathology of tumours of the nervous system ,(1977)
P. Kleihues, Webster K Cavenee, None, Pathology and genetics of tumours of the nervous system. International Agency for Research on Cancer. ,(2000)
E. W. Newcomb, Sandhya K. Bhalla, Clarissa L. Parrish, Roberta L. Hayes, Henry Cohen, Douglas C. Miller, bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status. Acta Neuropathologica. ,vol. 94, pp. 369- 375 ,(1997) , 10.1007/S004010050721
Arie Perry, Robert B. Jenkins, Judith R. O'Fallon, Paul L. Schaefer, David W. Kimmel, Michelle R. Mahoney, Bernd W. Scheithauer, Sandra M. Smith, Eunice M. Hill, Thomas J. Sebo, Ralph Levitt, James Krook, Loren K. Tschetter, Roscoe F. Morton, Jan C. Buckner, Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expression. Cancer. ,vol. 86, pp. 672- 683 ,(1999) , 10.1002/(SICI)1097-0142(19990815)86:4<672::AID-CNCR17>3.0.CO;2-G